DK0804210T3 - Fremgangsmåde til immunmodulering ved adoptiv overføring af antigenspecifikke cytotoksiske T-celler - Google Patents

Fremgangsmåde til immunmodulering ved adoptiv overføring af antigenspecifikke cytotoksiske T-celler

Info

Publication number: DK0804210T3
Authority: DK; Denmark
Prior art keywords: antigen; cells; ctls; immunomodulation; specific cytotoxic
Prior art date: 1994-05-16

Application number

DK94917635T

Other languages

English (en)

Inventor

Claudio Bordignon

Fulvio Mavilio

Original Assignee

Roche Diagnostics Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-16

Filing date

1994-05-16

Publication date

2003-03-10

1994-05-16 Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh

2003-03-10 Application granted granted Critical

2003-03-10 Publication of DK0804210T3 publication Critical patent/DK0804210T3/da

Links

210000001151 cytotoxic T lymphocyte Anatomy 0.000 title abstract 7
239000000427 antigen Substances 0.000 title abstract 6
108091007433 antigens Proteins 0.000 title abstract 6
102000036639 antigens Human genes 0.000 title abstract 6
230000002519 immonomodulatory effect Effects 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
210000004027 cell Anatomy 0.000 abstract 3
239000003550 marker Substances 0.000 abstract 2
238000002360 preparation method Methods 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
230000003213 activating effect Effects 0.000 abstract 1
238000011534 incubation Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000002062 proliferating effect Effects 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/46—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
- A61K2239/48—Blood cells, e.g. leukemia or lymphoma
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Cell Biology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK94917635T 1994-05-16 1994-05-16 Fremgangsmåde til immunmodulering ved adoptiv overføring af antigenspecifikke cytotoksiske T-celler DK0804210T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/EP1994/001573 WO1995031208A1 (en)	1994-05-16	1994-05-16	Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells

Publications (1)

Publication Number	Publication Date
DK0804210T3 true DK0804210T3 (da)	2003-03-10

Family

ID=8165855

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94917635T DK0804210T3 (da)	1994-05-16	1994-05-16	Fremgangsmåde til immunmodulering ved adoptiv overføring af antigenspecifikke cytotoksiske T-celler

Country Status (11)

Country	Link
EP (1)	EP0804210B1 (da)
JP (1)	JP3288708B2 (da)
KR (1)	KR100219258B1 (da)
AT (1)	ATE228368T1 (da)
AU (1)	AU691501B2 (da)
DE (1)	DE69431808T2 (da)
DK (1)	DK0804210T3 (da)
ES (1)	ES2186686T3 (da)
NO (1)	NO319331B1 (da)
PT (1)	PT804210E (da)
WO (1)	WO1995031208A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6063375A (en) *	1996-09-10	2000-05-16	Medical University Of South Carolina	Semiallogeneic cell hybrids and related methods for treating cancer
GB0224442D0 (en)	2002-10-21	2002-11-27	Molmed Spa	A delivery system
KR100882445B1 (ko)	2007-03-16	2009-02-09	울산대학교 산학협력단	항―４－１ｂｂ 항체를 이용한 항원 특이적 자가유래ｃｄ８＋ｔ 세포의 분리 및 증식 방법
EP3101122B1 (en)	2009-08-24	2023-06-14	Baylor College of Medicine	Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
GB201121308D0 (en)	2011-12-12	2012-01-25	Cell Medica Ltd	Process
PL3591047T3 (pl)	2012-02-09	2022-12-05	Baylor College Of Medicine	Mieszanki peptydowe do wytwarzania wielowirusowych ctl o szerokiej swoistości
EP3350600A4 (en)	2015-09-18	2019-04-17	Baylor College of Medicine	DISTINCTION OF AN IMMUNOGENIC ANTIGEN OF A PATHOGEN AND CORRELATION WITH CLINICAL EFFECTIVENESS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992005262A1 (en) *	1990-09-14	1992-04-02	The John Hopkins University	Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
US5529774A (en) *	1991-08-13	1996-06-25	The Regents Of The University Of California	In vivo transfer of the HSV-TK gene implanted retroviral producer cells

1994
- 1994-05-16 JP JP52929995A patent/JP3288708B2/ja not_active Expired - Lifetime
- 1994-05-16 KR KR1019960706486A patent/KR100219258B1/ko not_active Expired - Lifetime
- 1994-05-16 EP EP94917635A patent/EP0804210B1/en not_active Expired - Lifetime
- 1994-05-16 DK DK94917635T patent/DK0804210T3/da active
- 1994-05-16 DE DE69431808T patent/DE69431808T2/de not_active Expired - Lifetime
- 1994-05-16 WO PCT/EP1994/001573 patent/WO1995031208A1/en not_active Ceased
- 1994-05-16 ES ES94917635T patent/ES2186686T3/es not_active Expired - Lifetime
- 1994-05-16 AU AU69281/94A patent/AU691501B2/en not_active Expired
- 1994-05-16 PT PT94917635T patent/PT804210E/pt unknown
- 1994-05-16 AT AT94917635T patent/ATE228368T1/de active
1996
- 1996-11-18 NO NO19964896A patent/NO319331B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DE69431808T2 (de)	2003-09-18
EP0804210B1 (en)	2002-11-27
KR100219258B1 (ko)	1999-09-01
ES2186686T3 (es)	2003-05-16
JPH09507643A (ja)	1997-08-05
PT804210E (pt)	2003-04-30
EP0804210A1 (en)	1997-11-05
AU691501B2 (en)	1998-05-21
JP3288708B2 (ja)	2002-06-04
NO964896L (no)	1996-11-18
NO964896D0 (no)	1996-11-18
WO1995031208A1 (en)	1995-11-23
DE69431808D1 (de)	2003-01-09
NO319331B1 (no)	2005-07-18
ATE228368T1 (de)	2002-12-15
AU6928194A (en)	1995-12-05

Publication	Publication Date	Title
WO2001051616A3 (en)	2002-04-04	Techniques for growth and differentiation of human pluripotent stem cells
NO984314L (no)	1998-11-17	Cellekulturmedium for pattedyrceller
TR199902184T2 (xx)	1999-12-21	Sa� nakli y�ntemi
DK0804210T3 (da)	2003-03-10	Fremgangsmåde til immunmodulering ved adoptiv overføring af antigenspecifikke cytotoksiske T-celler
PT1071747E (pt)	2004-12-31	Linhas celulares imortalizadas derivadas de tecidos cutaneos humanos normais
CN109402045A (zh)	2019-03-01	一种水牛精原干细胞样细胞的体外培养及传代方法
NZ522337A (en)	2004-12-24	Production of TcR gamma delta T cells
CA2190261A1 (en)	1995-11-23	Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
EP0061253A3 (en)	1982-12-08	Process for the transfer of genetic material into actinomycete cells, prepared cells and method of culturing these cells and isolating a metabolite
AU2088997A (en)	1997-10-01	Method of identifying mhc-class i restriced antigens endogenously processed by a cellular secretory pathway
AU570954B2 (en)	1988-03-31	Propagation of proliferating cell aggregates
Wilson et al.	1987	Biochemistry of hybridoma technology
Bodey et al.	1996	Cell culture observations of human postnatal thymic epithelium: an in vitro model for growth and humoral influence on intrathymic T lymphocyte maturation.
EP0855441A3 (en)	2002-04-17	Isolation and purification of germinal stem cell using magnetic bead functioning as antibody and method for establishing stem cell line
SLASHCHEVA et al.	1985	Effect of space flight factors on Chlorella(Vliianie faktorov kosmicheskogo poleta na khlorellu)
CN109385395A (zh)	2019-02-26	一种用于体外培养的水牛精原干细胞样细胞的纯化方法
DeFreitas	1985	Human antigen-specific T hybridomas
TW364924B (en)	1999-07-21	Three new cell lines derived from pupal ovaries of Spodoptera litura
MX9707195A (es)	1997-11-29	Metodo de cultivo celular.